Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview
出版年份 2019 全文链接
标题
Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview
作者
关键词
Chemotherapy-induced peripheral neuropathy, CIPN, Neuropathy
出版物
SUPPORTIVE CARE IN CANCER
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-31
DOI
10.1007/s00520-019-04987-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent developments of novel pharmacologic therapeutics for prevention of chemotherapy-induced peripheral neuropathy
- (2019) Shuiying Hu et al. CLINICAL CANCER RESEARCH
- Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
- (2019) Alex Molassiotis et al. Brain and Behavior
- Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
- (2018) Galen E B Wright et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
- (2018) Alix F. Leblanc et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci
- (2018) Lara E. Sucheston-Campbell et al. Pharmacogenetics and Genomics
- Using stratified medicine to understand, diagnose, and treat neuropathic pain
- (2018) Andreas C. Themistocleous et al. PAIN
- Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia
- (2018) Nathalie K. Zgheib et al. Pharmacogenetics and Genomics
- A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer
- (2018) Hailey W. Bulls et al. GYNECOLOGIC ONCOLOGY
- Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients
- (2017) Chiara Campo et al. HEMATOLOGICAL ONCOLOGY
- Increased risk of paclitaxel-induced peripheral neuropathy in patients using clopidogrel: a retrospective pilot study
- (2017) Mitsuhiro Matsuo et al. Journal of Anesthesia
- CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer
- (2017) Jodi L. Skiles et al. PEDIATRIC BLOOD & CANCER
- Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathy
- (2017) Emily Cox-Martin et al. SUPPORTIVE CARE IN CANCER
- Impact of chemotherapy-induced neurotoxicities on adult cancer survivors’ symptom burden and quality of life
- (2017) Christine Miaskowski et al. Journal of Cancer Survivorship
- Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy
- (2017) Annelot G.J. van Rosssum et al. Oncotarget
- Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer
- (2017) Xiao Song et al. Scientific Reports
- Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
- (2017) Hana Starobova et al. Frontiers in Molecular Neuroscience
- Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103.
- (2017) B. P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease
- (2016) Guy M. Lenk et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
- (2016) M. Joerger et al. ANNALS OF ONCOLOGY
- Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients
- (2016) Siu W Lam et al. BRITISH JOURNAL OF CANCER
- A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
- (2016) F. Magrangeas et al. CLINICAL CANCER RESEARCH
- Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy
- (2016) D. L. Hertz et al. CLINICAL CANCER RESEARCH
- An Inherited Genetic Variant inCEP72Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia
- (2016) W Stock et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array
- (2016) Ramón García-Sanz et al. HEMATOLOGICAL ONCOLOGY
- Sensitivity analysis of gene ranking methods in phenotype prediction
- (2016) Enrique J. deAndrés-Galiana et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials
- (2016) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations
- (2016) Anna Hucke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population
- (2016) Angela Gutierrez-Camino et al. Pharmacogenetics and Genomics
- Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel
- (2016) Kuş Tulay et al. OncoTargets and Therapy
- Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans
- (2016) Bryan P. Schneider et al. Oncotarget
- Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
- (2016) Ganesh K. Boora et al. Cancer Medicine
- Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
- (2015) Lise Eckhoff et al. ACTA ONCOLOGICA
- Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review
- (2015) C.N. Frederiks et al. CANCER TREATMENT REVIEWS
- Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
- (2015) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients
- (2015) Cassandra Johnson et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
- (2015) Ganesh K. Boora et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- RWDD3andTECTAvariants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1
- (2014) Amit A. Kulkarni et al. ACTA ONCOLOGICA
- Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy
- (2014) Daniel L. Hertz et al. BREAST CANCER RESEARCH AND TREATMENT
- Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia
- (2014) Quentin Chalret du Rieu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The genetic variants underlying breast cancer treatment-induced chronic and late toxicities: A systematic review
- (2014) Terence Ng et al. CANCER TREATMENT REVIEWS
- Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel
- (2014) J. E. Abraham et al. CLINICAL CANCER RESEARCH
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis
- (2014) Xin Zhang et al. TUMOR BIOLOGY
- Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study
- (2013) A. Custodio et al. ANNALS OF ONCOLOGY
- Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
- (2013) J. A. Sprowl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study
- (2013) J. S. Gewandter et al. SUPPORTIVE CARE IN CANCER
- GWAS-based association betweenRWDD3andTECTAvariants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients
- (2012) Troels K. Bergmann et al. ACTA ONCOLOGICA
- Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity
- (2011) Romain Guilhaumou et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine
- (2011) A. Backshall et al. CLINICAL CANCER RESEARCH
- Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
- (2011) David C. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach
- (2011) Andrew S Moore et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
- (2011) Philippe Moreau et al. LANCET ONCOLOGY
- Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide
- (2011) María Teresa Cibeira et al. LEUKEMIA RESEARCH
- Genetic variation associated with bortezomib-induced peripheral neuropathy
- (2011) Reyna Favis et al. Pharmacogenetics and Genomics
- Risk of Chemotherapy-Induced Peripheral Neuropathy in Large Population-Based Cohorts of Elderly Patients With Breast, Ovarian, and Lung Cancer
- (2010) Zhannat Nurgalieva et al. AMERICAN JOURNAL OF THERAPEUTICS
- Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study
- (2010) Keiichiro Ishibashi et al. International Journal of Clinical Oncology
- Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia
- (2010) Akinbode Egbelakin et al. PEDIATRIC BLOOD & CANCER
- STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement
- (2009) Julian Little et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search